Navigation Links
Dominion Diagnostics Supports Opioid Risk Management Program for Fourth Consecutive Year

NORTH KINGSTOWN, R.I., June 8, 2011 /PRNewswire/ -- Leading national medication monitoring company, Dominion Diagnostics, announces its support of Tufts Health Care Institute's (THCI) Program on Opioid Risk Management for a fourth consecutive year.

Dominion's support of THCI's Program on Opioid Risk Management began in 2007 as part of the company's commitment to promoting the safe and effective use of controlled opioid medications commonly prescribed for chronic pain patients.  The Program aims to address the need to provide chronic pain patients with adequate opioid pharmacotherapy that enhances individual patient care while simultaneously reducing the risk of abuse and/or diversion.

"The mission of THCI's Opioid Risk Management Program is paramount to raising the standard of care for chronic pain patients and addressing the rapidly growing epidemic of prescription drug misuse," says Bob Garvey, Dominion's Chief Executive Officer. "It has become essential to engage such a diverse group of stakeholders in the development and implementation of programs that support prescription adherence, improve patient outcomes, and minimize risk through education, innovative clinical support, and evidence-based quality care."

Through a series of summit meetings each year, the THCI Opioid Risk Management Program provides a unique educational forum to encourage discussion among industry thought leaders.  Summit meeting participants, including Dominion's representatives, review scientific and health industry findings relevant to opioid risk management, and discuss recommendations for future initiatives. The THCI Opioid Risk Management Program has distinguished itself nationally as a high value medium for its exchange of ideas, implementation of awareness goals, and resulting collaborations for research and publication.

Dominion will participate in a two-day summit this week that will focus on pharmacotherapy for prescription opioid addiction and the implications for pain management with other participants in the THCI Opioid Risk Management Program.  For more information on the THCI Opioid Risk Management Program, please visit

About Dominion Diagnostics  

Dominion Diagnostics is a leading national medication monitoring company that offers comprehensive drug testing, scientifically accurate medication monitoring services and a full suite of clinical support solutions. Since 1997, Dominion has provided services to thousands of clients representing a diversity of medical specialties across the United States, including pain medicine, addiction medicine, behavioral health, primary care, psychiatry, and hospital systems.  Dominion is supported by a world-class team that shares a commitment to clinical and operational excellence.  For more information, please visit

For Media Inquiries, contact:
Julie K. Lenahan, MBA, Director of Marketing
Tel: (401) 667-0876, E-Mail:

SOURCE Dominion Diagnostics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials
2. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
3. Quest Diagnostics to Speak at the Jefferies 2011 Global Healthcare Conference
4. Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
5. Boston Heart Lab Changes Name to Boston Heart Diagnostics
6. Exagen Diagnostics Inc. Partners with Medco Research Institute® to Develop NIMBLE Personalized Medicine Program for Rheumatoid Arthritis Patients
7. Quest Diagnostics Successfully Completes Acquisition of Celera
8. Quest Diagnostics Declares Quarterly Cash Dividend
9. eCardio Diagnostics Announces Three Executive Appointments to Chief Operating Officer, Chief Technology Officer and Executive Vice President
10. VIDA Diagnostics Launches Apollo Pulmonary Analysis Software for Major Lung Disease at American Thoracic Society Meeting
11. Siemens Showcases New Innovations in Clinical Diagnostics, Automation, and IT at IFCC-WorldLab Berlin 2011
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):